2012-07-25 16:00:00 CEST

2012-07-25 16:01:00 CEST


REGULATED INFORMATION

English
Össur hf. - Financial Statement Release

Össur - Second Quarter Report 2012 


MODERATE SALES GROWTH

Sales  - Sales growth  was moderate, 3% measured  in local currency. Total sales
amounted to USD 103 million compared to USD 105 million in the second quarter of
2011. Sales  growth for  bracing and  supports was  moderate or  4%, measured in
local  currency. Sales growth  in prosthetics was  flat or 1%, measured in local
currency.

Profitability  - Net profit  amounted to USD  10 million or 10% of sales. EBITDA
amounted  to USD 19 million or 19% of sales and gross profit amounted to USD 64
million or 62% of sales.

Jón Sigurðsson, President & CEO, comments:"We are pleased to announce that the SYMBIONIC LEG, introduced last year is now
available in all main markets. The introduction has been successful and feedback
from users very positive. Sales growth in the second quarter was moderate.
Overall performance is affected by weak prosthetics sales in Americas.
Conservative sentiment in the US prosthetics market, due to audits from the
reimbursement systems, continues to affect customer behavior. Performance in
other major markets is however good, especially for prosthetics in EMEA and in
Asia where we had excellent growth in the quarter."

Full commercial launch of SYMBIONIC LEG - The SYMBIONIC LEG, the latest addition
to  Össur's Bionic Platform, is now available in all main markets. The SYMBIONIC
LEG  unites the proven capabilities of RHEO  KNEE and PROPRIO FOOT into a single
integrated  unit offering  unprecedented functionality  for above knee amputees.
This revolutionary new product is the first of its kind in the world.

Oscar  Pistorius selected  for the  South African  national athletics team - The
South  African  sprinter  Oscar  Pistorius  is  the first amputee sprinter to be
selected  to compete among able-bodied athletes on the world stage. Often called"Blade  Runner", Oscar competes on Össur's Flex-Foot Cheetah prosthetic legs and
has  been selected to  compete in the  individual men's 400m and 4x400m relay on
behalf of Team South Africa.

Global  Marketing -  To increase  Össur's competitive  edge in a changing market
more  focus  will  be  on  effectively  communicating  the  outcomes  of Össur's
solutions.  To  facilitate  this  and  further  add  value  to  Össur's customer
experience  a global marketing division has  been established that will function
across divisions and geographical locations.

Guidance  2012 - The  guidance for  the full  year of  2012 is organic LCY sales
growth in the range of 4-6% and adjusted EBITDA margin in the range of 20-21% of
sales.   However, due to  current negative sentiment  in the Americas prosthetic
market  and slowdown in prosthetics sales  in the region, management expects the
results  of 2012 to be  in the lower  end of the  guided range, both in terms of
sales and EBITDA.



Conference call tomorrow 26 July at 12:00 CET/ 10:00 GMT/ 6:00 EST

Tomorrow,  Thursday 26 July  Jón Sigurðsson,  President and  CEO, and Hjörleifur
Pálsson,  CFO, will host a conference call presenting and discussing the results
of  the second quarter of 2012. The conference call will be conducted in English
and can be heard on Össur's website: www.ossur.com

To  participate  in  the  meeting  please  call  one  of the following telephone
numbers:
Europe: +44 (0)20 3043 2436 or +46 (0)8 505 598 53
The United States: +1 866 458 40 87
Iceland: 800 8660


[HUG#1629282]